Hutchison China Meditech Competitors and Similar CompaniesClear all

Hutchison China Meditech's competitors and similar companies include Novartis, Pfizer, Fortrea and Moderna.

	Hutchison China Meditech Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.	Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products.	Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.	Fortrea Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO).	Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
Founding Date	Founding Date 2000	Founding Date 1996	Founding Date 1849	Founding Date 2023	Founding Date 2010
Type	Type Public	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma
Locations	Locations Shanghai, CN HQ Beijing, CN Jiangsu, CN Shanghai, CN Shanghai, CN Hong Kong, HK Hong Kong, HK see more	Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more	Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more	Locations Durham, US HQ Buenos Aires, AR Melbourne, AU Sydney, AU Zaventem, BE Sao Paulo, BR Sofia, BG see more	Locations Cambridge, US HQ Melbourne, AU Paris, FR München, DE Tokyo, JP Seoul, KR Warszawa, PL see more
Employees	Employees 1,811	Employees 75,883	Employees 81,0008% decrease	Employees 19,000	Employees 5,8004% increase
Valuation ($)	Valuation ($) 3.6 b	Valuation ($) N/A	Valuation ($) 163.9 b	Valuation ($) 1.6 b	Valuation ($) 21.2 b
Financial
Revenue (est.)	Revenue (est.) $548.5m (FY, 2025)	Revenue (est.) $56.7b (FY, 2025)	Revenue (est.) $62.6b (FY, 2025)	Revenue (est.) $2.7b (FY, 2025)	Revenue (est.) $1.9b (FY, 2025)
Cost of goods	Cost of goods $324.4m (FY, 2025)	Cost of goods $8.4b (FY, 2025)	Cost of goods $16.1b (FY, 2025)	Cost of goods N/A	Cost of goods $868m (FY, 2025)
Gross profit	Gross profit $224.2m (FY, 2025)	Gross profit $49.8b (FY, 2025)	Gross profit $46.5b (FY, 2025)	Gross profit N/A	Gross profit $1.1b (FY, 2025)
Net income	Net income $435.1m (FY, 2025)	Net income $14b (FY, 2025)	Net income $7.8b (FY, 2025)	Net income ($986.2m) (FY, 2025)	Net income ($2.8b) (FY, 2025)
Operating ⚠
Countries	Countries N/A	Countries N/A	Countries 200 (FY, 2024)	Countries 90 (Jul, 2023)	Countries N/A
Phase III Trials Products	Phase III Trials Products N/A	Phase III Trials Products 44 (FY, 2022)	Phase III Trials Products 32 (FY, 2024)	Phase III Trials Products N/A	Phase III Trials Products N/A
Registration Phase Products	Registration Phase Products N/A	Registration Phase Products 8 (FY, 2022)	Registration Phase Products 5 (FY, 2024)	Registration Phase Products N/A	Registration Phase Products N/A
Funding
Total funding raised	Total funding raised $ 100m	Total funding raised $ 6.5m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 1.8b